Determinants of postprandial lipemia in obese women

International Journal of Obesity

Volumn 23, Issue , 1999, Pages 14-21

  Vansant, Greet ^a   Mertens, A ^a   Muls, E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Apolipoprotein E; Intra abdominal fat; Obesity; Postprandial lipemia; Retinyl palmitate; Triglyceride

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; PALMITIC ACID; RETINOL; RETINOL ESTER; TRIACYLGLYCEROL;

ABDOMEN; ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; BLOOD SAMPLING; BODY FAT; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID DIET; MAJOR CLINICAL STUDY; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; APOLIPOPROTEINS E; BODY MASS INDEX; FASTING; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LIPIDS; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD;

EID: 0033028436     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800790     Document Type: Article

References (52)

1. Bengtsson C, Bjorkelund C, Lapidus L, Lissner L. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow-up of participants in prospective population studies in Gothenburg, Sweden. BMJ 1993; 307: 1385-1388.
2. Ducimetiere P, Richard J, Combien F. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: The Paris Prospective Study. Int J Obes 1986; 10: 229-240.
3. Després JP. Dyslipidaemia and obesity. Baillieré’s Clin Endocrinol Metab 1994; 8: 629-660.
4. Seidell JC, Bjorntorp P, Sjostrom L, Sonnerstedt R, Krot-kiewski M, Kvist H. Regional distribution of muscle and fat mass in men-New insight into the risk of abdominal obesity using computed tomography. Int J Obes 1989; 13: 289-303.
5. Despres JP, Mooijani S, Ferland M, Tremblay A, Lupien PJ, Nadeau A, Pinault S, Theriault G, Bouchard C. Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis 1989; 9: 203-210.
6. Pouliot MC, Despres JP, Moorjani S, Lupien PJ, Tremblay A, Bouchard C. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J Lipid Res 1990; 31: 1023-1029.
7. Uusitupa MIJ, Karhunen L, Rissanen A, Franssila-Kallunki A, Niskanen L, Kervinen K, Kesaniemi YA. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am J Clin Nutr 1996; 64: 131-136.
8. Van Gaal L, Vansant G, Van Campenhout C, Lepoutre L, De Leeuw I. Apolipoprotein concentrations in obese subjects with upper and lower body fat mass. Int J Obes 1989; 13: 255-263.
9. Van Gaal L, Vansant G, De Leeuw I. Upper body adiposity and the risk for atherosclerosis. J Am Coll Nutr 1989; 6: 597-601.
10. Després JP, Allard C, Tremblay A, Talbot J, Bouchard C. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism1985; 34: 967-973.
11. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485.
12. Patsch JR. Postprandial lipaemia. Baillierè’s Clin Endocrinol Metab 1987; 1: 551-580.
13. Groot PHE, Van Stiphout AHJ, Krauss XH, Jansen H, Van Tol A, Van Ramhorst E, Chin-On S, Hofman A, Creswell SR, Havekes L. Postprandial lipoprotein metabolism in normolipi-demic men with and without coronary artery disease. Arter-ioscler Thromb 1991; 11: 653-662.
14. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. Postprandial lipemia, Fenofibrate and coronary artery disease. Artherosclerosis 1990; 85: 193-202.
15. Patsch JR, Miesenback G, Hopferwieser T, Mahlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345.
16. Ryu JE, Howard G, Craven TE, Bond MG, Hageman AP, Crouse J III. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992; 23: 823-828.
17. Deurenberg P, Weststrate JP, Hautvast JGAJ. Changes in fat free mass during weight loss measured by bio-electrical impedance and by densitometry. Am J Clin Nutr 1989; 49: 33-36.
18. Hixson JE, Vernier DT. Restriction isotyping on human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548.
19. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988; 29: 469-479.
20. Karpe F, Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1995; 6: 123-129.
21. Krasinski SD, Cohn JS, Russell RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 1990; 39: 357-365.
22. Sprecher DL, Knauer SL, Black DM, Kaplan LA, Akeson AA, Dusing M, Lattier D, Stein EA, Rymaszewski M, Wiginton DA. Chylomicron-retinyl palmitate clearance in type I hyper-lipidemic families. J Clin Invest 1991; 88: 985-994.
23. Syvanne M, Talmud PJ, Humphries SE, Fisher RM, Rosse-neu M, Hilden H, Taskinen M-R. Determinants of post-prandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J Lipid Res 1997; 38: 1463-1472.
24. Den Ruyter MGM, De Leenheer AP. Simultaneous determination of retinyl and retinylesters in serum or plasma by reversed-phase high-performance liquid chromatography. Clin Chem 1987; 24: 1920-1923.
25. Wolever THS, Jenkins DJA. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 1986; 43: 167-172.
26. Brown AJ, Roberts DCK. The effect of fasting triacylglyce-ride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler Thromb 1991; 11: 1737-1744.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell functionfromfastingplasmaglucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
28. Miesenböck G, Patsch JR. Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Curr Opin Lipidol1992; 3: 196-201.
29. Wideman L, Kaminsky LA, Whaley MH. Postprandial lipemia in obese men with abdominal fat patterning. J Sports Med Phys Fitness 1996; 36: 204-210.
30. Lewis GF, O’Meara NM, Soltys PA, Blackman JD, Iverius PH, Druetzler AF, Getz GS, Polonsky KS. Postprandial lipoprotein metabolism in normal and obese subjects: Comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 1990; 71: 1041-1050.
31. Schneeman BO, Kotite L, Todd KM, Havel RJ. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl AcadSci USA 1993; 90: 2069-2073.
32. Jeppesen J, Chen Y-D I, Zhou M-Y, Wang T, Reaven GM. Effect of variations in oral fat and carbohydrate load on postprandial lipemia. Am J Clin Nutr 1995; 62: 1201-1205.
33. Glasbrenner B, Pieramico O, Brecht-Krauss D, Malfertheiner P. Gastric emptying of solids and liquids in obesity. Clin Invest1993; 71: 542-546.
34. Wisen O, Hellstrom PM. Gastrointestinal motility in obesity. J Intern Med 1995; 237: 411-418.
35. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997; 38: 2173-2192.
36. Muls E, Kempen K, Vansant G, Cobbaert C, Saris W. The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-1 and B, and lipoprotein(a). IntJObes 1993; 17: 711-716.
37. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571-1577.
38. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. Apolipoprotein E polymorphism influences postprandial reti-nyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994; 54: 341-360.
39. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H, Luley C. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype. Biochim Biophys Acta1996; 1303: 22-30.
40. Nikkila M, Solakivi T, Lehtimaki T, Koivula T, Laippala P, Astram B. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 1994; 106: 149-157.
41. Ryu JE, Craven TE, MacArthur RD, Hinson WH, Bond MG, Hagaman AP, Crouse JR Relationship of intraabdominal fat as measured by magnetic resonance imaging to postprandial lipemia in middle-aged subjects. Am J Clin Nutr 1994; 60: 586-591.
42. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993; 42: 1567-1573.
43. Arner P. Regulation of lipolysis in fat cells. Diabetes Rev1996; 4: 450-463.
44. Bonadonna RC, Bonora E. Glucose and free fatty acid metabolism in human obesity. Relationships to insulin resistance. Diabetes Rev 1997; 5: 21-51.
45. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann Med 1995; 27: 435-438.
46. Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci 1996; 90: 243-253.
47. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat b-adrenoceptors in obesity. J Clin Invest 1995; 95: 1109-1116.
48. Frayn KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4: 197-204.
49. Brunzell JD, Hazzard WR, Porte D, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest 1973; 52: 1578-1585.
50. Bjökegren J, Packard CJ, Hamsten A, Bedford D, Caslake M, Foster L, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996; 37: 76-86.
51. Jeppesen J, Hollenbeck CB, Zhou M-Y, Coulston AM, Jones C, Chen Y-D, Reaven GM. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995; 15: 320-324.
52. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.